Jorge Moscat#

Long CV

Citizenship: Spanish, US Permanent Resident (Green Card holder)
Marital Status: Married, 2 children
Present Position: Professor and Chairman, Department of Cancer and Cell Biology, University of Cincinnati College of Medicine

Education:

• 1975-1980 BS in Biochemistry, Universidad Complutense, Madrid
• 1981-1984 PhD in Biochemistry and Molecular Biology, Universidad Complutense, Madrid

Brief Chronology of Employment:

• 1983-1985, Researcher, Department of Internal Medicine, Hospital Clinico San Carlos, Madrid
• 1985-1990 Group Leader, Department of Experimental Medicine, Hospital Gregorio Marañón, Madrid
• 1987&1988 Guest Researcher, Laboratory of Cellular and Molecular Biology, National Cancer Institute, NIH, Bethesda, Maryland
• 1990-1993 Research Scientist (CSIC)
• 1993- Research Professor (CSIC), on Special Leave since July 2006
• 1996-2000 Director Laboratory GlaxoWellcome-CSIC of Molecular and Cellular Biology
• 1998-2002 Director of the Instituto de Biología Molecular (CSIC)
• 2004-2006 Scientific Coordinator of the Biology and Biomedicine Institutes of the Spanish National Research Council (CSIC)
• 2006-2008 Professor, Department of Genome Science, University of Cincinnati College of Medicine
• 2007-2008 Interim Chairman, Department of Genome Science/Molecular Oncogenesis, University of Cincinnati College of Medicine
• 2008- Professor and Chairman, Department of Cancer and Cell Biology, University of Cincinnati College of Medicine
• 2008-2011 Associate Director, University of Cincinnati Cancer Center
• 2011- Professor, NCI-Cancer Center, Sanford-Burnham Medical Research Institute
• 2012- Scientific Director, Cancer Metabolism, Sanford-Burnham Medical Research Institute
• 2013- Director, Cell Death and Survival Networks Program, NCI-Cancer Center, Sanford-Burnham Medical Research Institute
• 2013- Adjunct Professor, Department of Pharmacology, School of Medicine, University of California San Diego

Honours and Awards:

• 1980 Undergraduate Fellowship from Le Petit Pharmaceutical Laboratories (Dow Chemical Co.)
• 1981 Postgraduate Fellowship from the Spanish Education and Science Ministry
• 1982 Postgraduate Fellowship from the Spanish National Institute of Health
• 1984 Short-term Fellowship from Spanish Health Ministry, for studies in the Institute of Pharmacology "Mario Negri", Milano, Italy
• 1985 & 1986 Short-term Fellowships from the British Council to work at the Department of Biochemistry, AFRC Institute of Animal Physiology, Cambridge, U.K.
• 1987 Long-term Fellowship from "Juan March" Foundation to work at the National Cancer Institute, NIH, Bethesda, USA
• 1989 & 1991 Awards of the Spanish Cancer Scientific Association
• 1995 Elected member of the European Molecular Biology Organization (EMBO)
• 1998 Award of the Foundation for Health Sciences
• 1999 Award of the Spanish Royal Academy of Sciences
• 2000 Award of the Carmen and Severo Ochoa Foundation
• 2001 Award of the Juan March Foundation
• 2002 Member of the Editorial Board of EMBO Journal
• 2002 Member of the Editorial Board of EMBO Reports
• 2006 Elected Member of the Academia Europaea
• 2010-2012 Ad hoc member of NIH Cancer Molecular Pathobiology and Cancer Etiology Study Sections
• 2010 Member review panel NCI Cancer and Inflammation Program
• 2011 Member panel on NCI Provocative Questions (Salk Institute, La Jolla)
• 2012 - Permanent member of NIH Cancer Etiology Study Section
• 2012 Ad hoc member NIH Tumor Cell Biology Study Section
• 2012 - Member of the Scientific Advisory Board of the Institute for Diabetes and Obesity of the Helmholtz Zentrum München (Germany)

Main International Seminars

• Invited Speaker, Children's Hospital, Boston 1990
• Invited Speaker, Harvard Medical School, Boston 1991
• Invited Speaker, Glaxo U.K, London 1994
• Invited Speaker, Chester Beatty Laboratories, London 1995
• Invited Speaker, EMBL, Heidelberg 1995
• Invited Speaker, Friedrich Miescher-Institut, Basel 1995
• Invited Speaker, Dana Farber Cancer Institute, Boston 1995
• Invited Speaker, Tularik Inc., San Francisco 1996
• Invited Speaker, Glaxo-Wellcome U.K., Stevenage 1996
• Invited Speaker, Glaxo-Wellcome USA, RTP 1996
• Invited Speaker, National Cancer Institute, NIH, Bethesda 1996
• Invited Speaker, Friedrich Miescher-Institut, Basel 1997
• Invited Speaker, Mayo Clinic, Rochester Minnesota 1998
• Invited Speaker, Albert Einstein College of Medicine, New York 1999
• Invited Speaker, University of Virginia at Charlottesville, Virginia 2000
• Invited Speaker, Gent University, Gent 2000
• Invited Speaker, University of Illinois at Chicago, Chicago 2001
• Invited Speaker, Pfizer USA, Groton 2002
• Invited Speaker, Wyeth USA, Boston 2002
• Invited Speaker, Biogen Inc., Boston 2002
• Invited Speaker, University of Pittsburgh Medical Center, Pittsburgh 2002
• Invited Speaker, Institut de Biologie Moléculaire et Cellulaire-CNRS, Strasbourg 2003
• Invited Speaker, Cancer Center of the University of Illinois at Chicago 2003
• Invited Speaker, Pfizer USA, Saint Louis 2003
• Invited Speaker, Biogen-Idec, Boston 2004
• Invited Speaker, University of Cincinnati, Cincinnati 2005
• Invited Speaker, Cincinnati Children’s Hospital, Cincinnati 2006
• Invited Speaker, Washington University School of Medicine, Saint Lous 2007
• Invited Speaker, Brown University, Providence 2007
• Invited Speaker, Ohio State University Cancer Center, Columbus 2007
• Invited Speaker, Genentech, San Francisco 2009
• Invited Speaker, Harvard, Boston 2010
• Invited Speaker, Sanford-Burnham Medical Research Institute, San Diego 2010
• Invited Speaker, Indiana University, Indianapolis, 2010
• Invited Speaker, Spanish National Cancer Institue (CNIO), Madrid, 2010
• Invited Speaker, National Center of Biotechnology, Madrid, 2010
• Invited Speaker, Centre of Molecular Biology Severo Ochoa, Madrid, 2010
• Invited Speaker, Spanish National Cardiovascular Institute (CNIC), Madrid 2011
• Invited Speaker, University of California San Diego, 2012
• Invited Speaker, University of California Riverside, 2012
• Invited Speaker, University of California Davis, 2012
• Invited Speaker, University of California Santa Barbara, 2012
• Invited Speaker, Stony Brook Cancer Center, NY, 2013
• Invited Speaker, Loyola University School of Medicine, Chicago, 2013
• Invited Speaker, NIH-Frederick, Washington DC, 2013
• Invited Speaker, University of Southern California, Los Angeles, 2013
• Invited Speaker, University of California San Diego, Dept. Pharmacology, 2013
• Invited Speaker, University of California San Diego, Dept. Bioengineering, 2013
• Invited Speaker, Case Western Reserve, Cleveland, 2013